tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Mani Foroohar, 132 are a BUY (54.77%), 91 are a HOLD (37.76%), 18 are a SELL (7.47%).
Analyst Mani Foroohar, currently employed at LEERINK, carries an average stock price target met ratio of 53.52% that have a potential upside of 43.29% achieved within 220 days.
Mani Foroohar’s has documented 451 price targets and ratings displayed on 30 stocks. The coverage is on Healthcare, Technology sectors.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 03-Mar-2026.
Analyst best performing recommendations are on FDMT (4D MOLECULAR THERAPEUTICS ).
The best stock recommendation documented was for FDMT (4D MOLECULAR THERAPEUTICS ) at 11/14/2022. The price target of $15 was fulfilled within 1 day with a profit of $1.51 (11.19%) receiving and performance score of 111.93.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 17-Nov-2025
$5
$0.64 (14.68%)
4 months ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 23-Jul-2021
$5.5
$1.14 (26.15%)
$12
4 months 16 days ago
(29-Oct-2025)
1/6 (16.67%)
$1.27 (30.02%)
292
Buy Since 11-Aug-2023
7 months 4 days ago
(13-Aug-2025)
3/4 (75%)
$30.52 (321.94%)
884
Hold Since 29-Apr-2021
$4
$-0.36 (-8.26%)
$5
10 months 2 days ago
(15-May-2025)
3/5 (60%)
$1.95 (95.12%)
127
Buy Since 25-Jun-2024
$28
$23.64 (542.20%)
$28
1 years 5 months 3 days ago
(14-Oct-2024)
0/3 (0%)
$20.27 (262.23%)
Which stock is Mani Foroohar is most bullish on?
Which stock is Mani Foroohar is most reserved on?
What Year was the first public recommendation made by Mani Foroohar?
